Skip to main content

Table 2 Cox proportional hazards regression analyses of cancer-specific survival at the time of diagnosis and cancer-specific conditional survival for gallbladder cancer survivors at 1, 3, and 5 years after diagnosis

From: Conditional survival in patients with gallbladder cancer

Characteristics

At diagnosis (n = 9760)

1 year after diagnosis (n = 3232)

3 years after diagnosis (n = 1178)

5 years after diagnosis (n = 612)

Patients

CSD

HR (95% CI)

P value

Survivors

CSCD

HR (95% CI)

P value

Survivors

CSCD

HR (95% CI)

P value

Survivors

CSCD

HR (95% CI)

P value

Age at diagnosis (years)

 < 65

3056

1760 (57.6)

Reference

 

1223

477 (39.0)

Reference

 

470

63 (13.4)

Reference

 

251

15 (6.0)

Reference

 

 65–79

3975

2177 (54.8)

1.178 (1.104–1.256)

< 0.001

1339

472 (35.3)

1.038 (0.912–1.182)

0.574

493

71 (14.4)

1.117 (0.789–1.581)

0.534

261

15 (5.7)

0.971 (0.472–1.998)

0.937

 ≥ 80

2729

1495 (54.8)

1.584 (1.471–1.706)

< 0.001

670

213 (31.8)

1.271 (1.068–1.513)

0.007

215

32 (14.9)

1.504 (0.967–2.338)

0.070

100

4 (4.0)

0.885 (0.290–2.698)

0.830

Sex

 Men

3012

1633 (54.2)

Reference

 

956

349 (36.5)

NA

 

320

47 (14.7)

NA

 

158

11 (7.0)

NA

 

 Women

6748

3799 (56.3)

0.988 (0.931–1.049)

0.689

2276

813 (35.7)

  

858

119 (13.9)

  

454

23 (5.1)

  

Race

 White

7528

4148 (55.1)

Reference

 

2506

886 (35.4)

Reference

 

908

134 (14.8)

Reference

 

473

28 (5.9)

NA

 

 Black

1163

683 (58.7)

1.095 (1.009–1.189)

0.030

370

151 (40.8)

1.202 (1.009–1.432)

0.040

128

15 (11.7)

0.782 (0.455–1.346)

0.375

64

5 (7.8)

  

 Others

1040

596 (57.3)

0.997 (0.914–1.087)

0.945

347

125 (36.0)

1.005 (0.831–1.215)

0.958

139

17 (12.2)

0.861 (0.515–1.441)

0.569

73

1 (1.4)

  

 Unknown

29

5 (17.2)

0.374 (0.156–0.900)

0.028

9

0 (0.0)

NA (NA)

0.873

3

0 (0.0)

NA (NA)

0.970

2

0 (0.0)

  

Histology

 Non-papillary

9415

5343 (56.7)

Reference

 

3007

1120 (37.2)

Reference

 

1059

156 (14.7)

Reference

 

547

33 (6.0)

NA

 

 Papillary

345

89 (25.8)

0.550 (0.444–0.680)

< 0.001

225

42 (18.7)

0.622 (0.454–0.851)

0.003

119

10 (8.4)

0.792 (0.411–1.527)

0.486

65

1 (1.5)

  

Grade

 Grade 1–2

3648

1549 (42.5)

Reference

 

1821

580 (31.9)

Reference

 

716

105 (14.7)

Reference

 

372

25 (6.7)

NA

 

 Grade 3–4

2874

1760 (61.2)

1.523 (1.419–1.634)

< 0.001

790

353 (44.7)

1.152 (1.004–1.322)

0.043

243

40 (16.5)

0.744 (0.506–1.093)

0.132

121

6 (5.0)

  

 Unknown

3238

2123 (65.6)

1.144 (1.052–1.244)

0.002

621

229 (36.9)

0.776 (0.639–0.942)

0.010

219

21 (9.6)

0.703 (0.409–1.206)

0.200

119

3 (2.5)

  

T category

 T1

1520

525 (34.5)

Reference

 

817

160 (19.6)

Reference

 

433

34 (7.9)

Reference

 

257

9 (3.5)

Reference

 

 T2

2354

870 (37.0)

1.153 (1.032–1.289)

0.012

1276

361 (28.3)

1.358 (1.118–1.649)

< 0.002

504

61 (12.1)

1.446 (0.931–2.247)

0.101

241

12 (5.0)

1.346 (0.567–3.199)

0.501

 T3–4

4492

3033 (67.5)

2.356 (2.133–2.602)

< 0.001

979

551 (56.3)

2.916 (2.405–3.537)

< 0.001

212

62 (29.2)

3.948 (2.486–6.270)

< 0.001

99

13 (13.1)

3.388 (1.400–8.196)

0.007

 Unknown

1394

1004 (72.0)

1.897 (1.676–2.148)

< 0.001

160

90 (56.3)

2.629 (1.913–3.613)

< 0.001

29

9 (31.0)

7.250 (2.871–18.309)

< 0.001

15

0 (0.0)

NA (NA)

0.980

N category

 N0

5521

2601 (47.1)

Reference

 

2220

646 (29.1)

Reference

 

927

114 (12.3)

Reference

 

495

20 (4.0)

NA

 

 N1–2

2623

1683 (64.2)

1.213 (1.137–1.294)

< 0.001

786

407 (51.8)

1.493 (1.301–1.714)

< 0.001

188

41 (21.8)

1.272 (0.845–1.915)

0.248

82

12 (14.6)

  

 Unknown

1616

1148 (71.0)

1.277 (1.173–1.392)

< 0.001

226

109 (48.2)

1.230 (0.947–1.598)

0.120

63

11 (17.5)

1.088 (0.429–2.763)

0.858

35

2 (5.7)

  

M category

 M0

5594

2427 (43.4)

Reference

 

2665

831 (31.2)

Reference

 

1085

143 (13.2)

Reference

 

568

30 (5.3)

Reference

 

 M1

3266

2385 (73.0)

2.050 (1.912–2.199)

< 0.001

408

258 (63.2)

2.346 (1.987–2.769)

< 0.001

40

12 (30.0)

2.022 (1.040–3.932)

0.038

16

4 (25.0)

4.620 (1.476–14.457)

0.009

 Unknown

900

620 (68.9)

1.417 (1.274–1.575)

< 0.001

159

73 (45.9)

1.051 (0.784–1.409)

0.741

53

11 (20.8)

1.093 (0.447–2.675)

0.845

28

0 (0.0)

NA (NA)

0.976

Surgery

 No

3393

2427 (71.5)

Reference

 

348

190 (54.6)

Reference

 

55

4 (7.3)

Reference

 

32

1 (3.1)

Reference

 

 Yes

6321

2970 (47.0)

0.576 (0.532–0.624)

< 0.001

2873

968 (33.7)

0.754 (0.605–0.940)

0.012

1119

162 (14.5)

4.403 (1.466–13.219)

0.008

578

33 (5.7)

3.000 (0.372–24.190)

0.302

 Unknown

46

35 (76.1)

0.980 (0.684–1.404)

0.913

11

4 (36.4)

0.841 (0.299–2.365)

0.742

4

0 (0.0)

NA (NA)

0.969

2

0 (0.0)

NA (NA)

0.994

Radiotherapy

 No

8329

4694 (56.4)

Reference

 

2483

829 (33.4)

Reference

 

949

120 (12.6)

Reference

 

505

25 (5.0)

NA

 

 Yes

1254

641 (51.1)

0.740 (0.679–0.808)

< 0.001

687

314 (45.7)

1.195 (1.035–1.379)

0.015

215

45 (20.9)

1.378 (0.933–2.035)

0.107

100

9 (9.0)

  

 Unknown

177

97 (54.8)

0.876 (0.707–1.085)

0.225

62

19 (30.6)

0.897 (0.558–1.441)

0.653

14

1 (7.1)

0.583 (0.080–4.233)

0.594

7

0 (0.0)

  

Insurance

 No

1484

804 (54.2)

Reference

 

436

135 (31.0)

Reference

 

134

13 (9.7)

NA

 

47

0 (0.0)

NA

 

 Yes

5311

2766 (52.1)

0.891 (0.822–0.966)

0.005

1769

586 (33.1)

1.049 (0.867–1.269)

0.625

547

53 (9.7)

  

204

9 (4.4)

  

 Unknown

2965

1862 (62.8)

1.061 (0.975–1.155)

0.170

1027

441 (42.9)

1.154 (0.948–1.405)

0.154

497

100 (20.1)

  

361

25 (6.9)

  

Marriage

 No

4610

2603 (56.5)

Reference

 

1365

454 (33.3)

Reference

 

480

70 (14.6)

NA

 

237

15 (6.3)

NA

 

 Yes

4689

2591 (55.3)

0.904 (0.852–0.958)

0.001

1723

662 (38.4)

1.093 (0.965–1.239)

0.163

651

91 (14.0)

  

346

19 (5.5)

  

 Unknown

461

238 (51.6)

0.905 (0.792–1.035)

0.144

144

46 (31.9)

1.011 (0.746–1.371)

0.942

47

5 (10.6)

  

29

0 (0.0)

  
  1. Patients at the time of diagnosis and survivors at 1, 3, and 5 years after diagnosis are presented as number of cases. CSD and CSCD are presented as number of cases followed by percentage in parentheses
  2. CSD cancer-specific death, CSCD cancer-specific conditional death, HR hazard ratio, CI confidence interval, NA not applicable